¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ovarian tumours"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® ovarian cysts ÇÑ±Û ³­¼Ò³¶
¼³¸í   
  ³­¼Ò¿¡ ¹ß»ýÇÑ ³¶. ¿©±â¿¡´Â ´Ü¼øÇÑ ¹°È¤ÀΠ³¶ÀÌ ÀÖ°í Á¾¾ç¼º ³¶ÀÌ ÀÖ´Ù. ³¶À̶õ, ¸·À¸·Î µÑ·¯ ½Î¿©Á® ÀÖÀ¸¸ç, ¾È¿¡´Â ¾×ü°¡ Â÷Àִ º´Å͸¦ ¸»ÇÑ´Ù. ÀÌ·± ³¶ÇüÅÂÀÇ Á¾¾çÀ¸·Î´Â ÇǺθð¾ç³¶Á¾(dermoid cyst), ³¶»ùÁ¾(cystadenoma) µîÀÌ ÀÖ´Ù. À̵éÀÇ °¨º°Áø´ÜÀº È¯ÀÚÀÇ ¿¹ÈÄ¿¡ °áÁ¤ÀûÀ̹ǷΠ¹Ýµå½Ã ½ÃÇàµÇ¾î¾ß Çϳª, ±× ¹æ¹ýÀº ¼ö¼ú¿¡ ÀÇÇØ¼­ ³¶Á¾À» ÀýÁ¦ÇÏ¿© º´¸®ÇÐÀûÀ¸·Î ±¸ºÐÇϴ ¼ö¹Û¿¡ ¾ø´Ù.
¿µ¹® ovarian cancer ÇÑ±Û ³­¼Ò¾Ï
¼³¸í   
  ¿©¼ºÀÇ ³­¼Ò¿¡ ¹ß»ýÇϴ ¾Ï. ºÎÀΰúÁ¾¾çÀ¸·Î¼­ 50¼¼ À̻󠿩¼º¾Ç¼ºÁ¾¾çÀÇ ¾à 18%¸¦ Â÷ÁöÇÑ´Ù. Á¾¾çÀº ´ë°³ º¹ºÎ ±í¼÷È÷ À§Ä¡ÇϹǷΠÁ¾¾çÀÌ ¸¹ÀÌ ÁøÇàµÈ »óÅ¿¡¼­ ¹ß°ßµÇ´Â ¼ö°¡ ¸¹À¸¸ç, ¶ÇÇÑ Á¾¾çÀÇ Ãʱ⿡´Â Áõ»óÀÌ °ÅÀÇ ¾ø´Â °æ¿ì°¡ ¸¹¾Æ ´õ¿í Á¶±â¹ß°ßÀÌ ¾î·Æ´Ù.
  
  ¾ÆÁÖ ´Ù¾çÇÑ Á¾·ùÀÇ ¾ÏÀÌ ¹ß»ýÇϸç, ¿¹Èĵµ °¢±â ±× Á¾¾çÀÇ Á¾·ù¿¡ µû¶ó ´Ù¸£´Ù. ´ëÇ¥ÀûÀΠ¾ÏÀ¸·Î À强³¶»ù¾ÏÁ¾(serous cystadenocarcinoma), Á¡¾×³¶»ù¾ÏÁ¾(mucinous cystadenocarcinoma), Á¾ÀÚ¼¼Æ÷Á¾(germinoma µîÀÌ ÀÖ´Ù. Ä¡·á´Â ¼ö¼úÀû Ä¡·á°¡ ¼±ÇàµÇ¾î¾ß ÇÏÁö¸¸, ¸¹ÀÌ ÁøÇàµÇ¾î À̹̠´Ù¸¥ Á¶Á÷À¸·Î ÀüÀ̰¡ ÀÌ·ç¾îÁø »óÅ¿¡¼­´Â È­Çпä¹ýÀÌ ¼±ÅÃÀûÀ¸·Î »ç¿ëµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ovarian
    ³­¼Ò-
  • ovarian artery
    ³­¼Òµ¿¸Æ
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovarian cyst
    1. ³­¼Ò³¶, ³­¼Ò¹°È¤ 2. ³­¼Ò³¶Á¾
  • ovarian failure
    ³­¼Ò±â´É»ó½Ç
  • ovarian fimbria
    ³­¼Ò¼ú
  • ovarian fossa
    ³­¼Ò¿À¸ñ, ³­¼Ò¿Í
  • ovarian implantation
    ³­¼ÒÂø»ó
  • ovarian pregnancy
    ³­¼ÒÀÓ½Å
  • ovarian seminoma
    ³­¼Ò°íȯÁ¾
  • ovarian vein
    ³­¼ÒÁ¤¸Æ
  • polycystic ovarian syndrome
    ´Ù³¶³­¼ÒÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tubo-ovarian abscess
    Àڱðü³­¼Ò°í¸§Áý, Àڱðü³­¼Ò³ó¾ç
  • ovarian cyst
    1.³­¼Ò³¶, ³­¼Ò¹°È¤, 2.³­¼Ò³¶Á¾
  • ovarian fimbria
    ³­¼Ò¼ú
  • ovarian failure
    ³­¼Ò±â´É»ó½Ç, ³­¼ÒºÎÀü
  • ovarian pregnancy
    ³­¼ÒÀÓ½Å
  • polycystic ovarian syndrome
    ´Ù³¶³­¼ÒÁõÈıº, ¹µÁָӴϳ­¼ÒÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ovarian artery
    ³­¼Òµ¿¸Æ
  • tubo-ovarian abscess
    Àڱðü³­¼Ò°í¸§Áý, Àڱðü³­¼Ò³ó¾ç
  • borderline malignant epithelial ovarian neoplasm
    °æ°è¾Ç¼º»óÇdz­¼ÒÁ¾¾ç
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovarian fimbria
    ³­¼Ò¼ú
  • ovarian fossa
    ³­¼Ò¿À¸ñ
  • tertiary ovarian follicle
    »ïÂ÷³­Æ÷
  • ovarian implantation
    ³­¼ÒÂø»ó
  • ovarian pregnancy
    ³­¼ÒÀÓ½Å
  • ovarian seminoma
    (¢¡dysgerminoma) ¹ÌºÐÈ­¼¼Æ÷Á¾, ³­¼Ò»ý½Ä¼¼Æ÷Á¾
  • utero-ovarian varicocele
    Àڱó­¼ÒÁ¤¸Æ³¶Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antrum of ovarian follicle
    ³­Æ÷¹æ
  • polycystic ovarian disease
    ´Ù³¶³­¼Ò(ÒýÒ¥Õ°áµ), ´Ù³¶¼º ³­¼Òº´(ÒýÒ¥àõ Õ°áµÜ»)
  • polycystic ovarian syndrome
    ´Ù³¶¼º ³­¼ÒÁõÈıº.
  • primary ovarian follicle
    ÀÏÂ÷³­Æ÷
  • primary ovarian pregnancy
    ÀÏÂ÷³­¼ÒÀÓ½Å(¡­Õ°áµìôãã).
  • primordial ovarian follicle
    ¿ø½Ã³­Æ÷
  • proper ovarian ligament
    °íÀ¯³­¼ÒÀδë
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antrum of ovarian follicle
    ³­Æ÷¹æ
  • benign ovarian tumor
    ¾ç¼º³­¼ÒÁ¾¾ç
  • borderline malignant epithelial ovarian neoplasms
    °æ°è¼º »óÇǼº ³­¼ÒÁ¾¾ç
  • breast/ovarian familial cancer syndrome
    À¯¹æ/³­¼Ò °¡Á·¼º ¾ÏÁõÈıº
  • cyst,ovarian
    ³­¼Ò(Õ°áµ)
  • dysgerminoma,ovarian
    ³­¼ÒÁ¤»óÇÇÁ¾
  • epithelial ovarian cancer
    »óÇǼº ³­¼Ò¾Ï
  • left ovarian vein
    ¿Þ³­¼ÒÁ¤¸Æ
  • oogenetic cycle =ovarian c.
    ³­Àڹ߻ýÁÖ±â(Õ°í­Û¡ßæñÎÑ¢).
  • ovarian artery
    ³­¼Òµ¿¸Æ
  • ovarian artery
    ³­¼Òµ¿¸Æ
  • ovarian branch
    ³­¼Ò°¡Áö
  • ovarian branch
    ³­¼Ò°¡Áö
  • ovarian cycle
    ³­¼ÒÁÖ±â
  • ovarian cycle
    ³­¼ÒÁÖ±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Proper ovarian ligament
    °íÀ¯³­¼ÒÀδë
    [¿¾ ¿ë¾î] °íÀ¯³­¼Ò»è
  • Ovarian branch
    ³­¼Ò°¡Áö
    [¿¾ ¿ë¾î] ³­¼ÒÁö
  • Ovarian artery
    ³­¼Òµ¿¸Æ
    [¿¾ ¿ë¾î] ³­¼Òµ¿¸Æ
  • Ovarian fimbriae
    ³­¼Ò¼ú
    [¿¾ ¿ë¾î] ³­¼Òä
  • Ovarian plexus
    ³­¼Ò½Å°æ¾ó±â
    [¿¾ ¿ë¾î] ³­¼Òµ¿¸Æ½Å°æÃÑ
  • Ovarian fossa
    ³­¼Ò¿À¸ñ
    [¿¾ ¿ë¾î] ³­¼Ò¿Í
  • Ovarian pregnancy
    ³­¼ÒÀÓ½Å
    [¿¾ ¿ë¾î] ³­¼ÒÀÓ½Å
  • Ovarian cycle
    ³­¼ÒÁÖ±â
    [¿¾ ¿ë¾î] ³­¼ÒÁÖ±â
  • Ovarian implantation
    ³­¼ÒÂø»ó
    [¿¾ ¿ë¾î] ³­¼ÒÂø»ó
  • Antrum of ovarian follicle
    ³­Æ÷¹æ
    [¿¾ ¿ë¾î] ³­Æ÷µ¿
  • Stigma of ovarian follicle
    ¹è¶õÁ¡
    [¿¾ ¿ë¾î] ³­Æ÷¹®
  • Tertiary ovarian follicle [Vesicular follicle, Graafian foll
    »ïÂ÷³­Æ÷
    [¿¾ ¿ë¾î] »ïÂ÷³­Æ÷
  • Vesicular ovarian follicle
    »ïÂ÷³­Æ÷
    [¿¾ ¿ë¾î] Æ÷»ó³­Æ÷
  • Right ovarian vein
    ¿À¸¥³­¼ÒÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ì³­¼ÒÁ¤¸Æ
  • Left ovarian vein
    ¿Þ³­¼ÒÁ¤¸Æ
    [¿¾ ¿ë¾î] Á³­¼ÒÁ¤¸Æ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accessory ovarian lobe
    ³­¼ÒºÎ¿±
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ovarian
    ³­¼ÒÀÇ
  • ovarian cancer
    ³­¼Ò¾Ï
  • ovarian cyst
    ³­¼Ò³¶
  • ovarian dysfunction
    ³­¼Ò±â´ÉÀÌ»ó
  • ovarian hormone
    ³­¼ÒÈ£¸£¸ó
  • ovarian insufficiency
    ³­¼Ò(±â´É)ºÎÀü
  • ovarian ligament
    ³­¼ÒÀδë
  • ovarian pregnancy
    ³­¼ÒÀÓ½Å
  • ovarian tumor
    ³­¼ÒÁ¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OCAA Ovarian Cystadenocarcinoma Associated Antigen; Serous Mucinous Ovarian Tumor¿¡¸¸ ³ªÅ¸³²
POF pattern of failure; position of function; premature ovarian failure; primary ovarian failure; pyruva...
PCOS Poly-Cystic Ovary(Ovarian) Syndrome
TOA Tubo-Ovarian Abscess
HBOC hereditary breast-ovarian cancer
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MMT Mixed Mullerian Tumours
CHO Chinese Hamster Ovarian
COH Compensatory ovarian hypertrophy
COH Controlled ovarian hyperstimulation
EOC Epithelial Ovarian Cancer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • borderline malignant epithelial ovarian neoplasms
    °æ°è¼º »óÇǼº ³­¼Ò Á¾¾ç
  • ovarian
    ³­¼ÒÀÇ
    ³­¼Ò
  • ovarian apoplexy
    ³­¼ÒÁ¹Áß
    ³­¼Ò ³»·ÎÀÇ ±¤¹üÀ§ÇÑ ÃâÇ÷.
  • ovarian duct
    ³­°ü
  • ovarian tumor
    ³­¼Ò Á¾¾ç
    ³­¼Ò¿¡¼­ »ý±â´Â Á¾¾ç. ³­¼Ò´Â ÀÎüÀÇ Àå±â Áß¿¡¼­ °¡Àå ¸¹Àº Á¾·ùÀÇ Á¾¾çÀÌ ¹ß»ýÇÏ´Â ±â°üÀÌ¸ç ±× ºÐ·ù¹ýµµ ´Ù¾çÇØ, ¿©·¯ °¡Áö À̸§À¸·Î ºÒ¸°´Ù. ÀÓ»óÀûÀ¸·Î´Â ¾ç¼º, ¾Ç¼º, Áß°£¼ºÀÇ ¼¼ °¡Áö·Î ´ëº°µÇÁö¸¸ °¨º°ÀÌ °ï¶õÇÑ °æ¿ìµµ ÀÖ´Ù. ´ëü·Î Ãæ½ÇºÎ°¡ ÀüÇô ¾ø´Â ¼ø³¶Æ÷¼ºÀÇ °ÍÀ» ³¶Æ÷¼º Á¾¾çÀ̶ó ÇÏ¸ç ¾ç¼ºÀÌ´Ù. Ãæ½ÇºÎ·Î µÇ¾î ÀÖ´Â °æ¿ì¸¦ Ãæ½Ç¼º Á¾¾çÀ̶ó Çϸç, ³¶Æ÷ºÎ¿Í Ãæ½ÇºÎ°¡ ¼¯¿© ÀÖ´Â °æ¿ì¸¦ ¹ÝÃæ½Ç¼º Á¾¾çÀ̶ó Çϴµ¥ ÀÌ µÎ °¡Áö¸¦ ÇÕÃļ­ Ãæ½Ç¼º Á¾¾çÀ̶ó ÇÑ´Ù.
  • ovarian-remnant syndrome
    ÀÜÀ¯ ³­¼Ò ÁõÈıº
    ³­¼Ò ÀûÃâ¼ú ÈÄ, ¸î ÁÖ³»Áö´Â ¸î °³¿ù µÚ¿¡ °ñ¹ÝÅëÀÌ ¿À´Â °ÍÀ¸·Î, Ȳü ³¶Á¾ µîÀÇ °ñ¹Ý Á¾±«¿Í ¿¬°üµÇ¾î ÀÖÀ¸¸ç, ¶§¶§·Î ÆíÃøÀÇ ¿ä°ü Æó»öÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù. À̰ÍÀº ¼ö¼ú ÈÄ ³­¼Ò Á¶Á÷ÆíÀÌ ³²¾Æ Àֱ⠶§¹®ÀÌ´Ù.
  • polycystic ovarian disease
    ´Ù³¶ ³­¼Ò Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
ovarian tumours <radiology> Before age 45 most likely to be 98% benign, 2/3 of cancers in ages 40 - 65 yrs see also: ovarian stromal tumours
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ovarian stromal tumours <radiology> Age 20 - 50 yrs, 20% of all ovarian tumours, fibroma / fibrosarcoma, granulosa-theca cell tumour, with or without oestrogens most likely to be precocious puberty, endometrial hyperplasia/carcinoma, fibrocystic breast disease, Sertoli-Leydig cell tumour, aka: arrhenoblastoma, with or without androgens most likely to be masculinization, may be mixed type
(12 Dec 1998)
benign liver tumours <radiology> EPITHELIAL TUMORS, nodular transformation, focal nodular hyperplasia, hepatocellular adenoma, MESENCHYMAL TUMORS, lipoma, myelolipoma, angiomyolipoma, leiomyoma, infantile haemangioendothelioma, haemangioma, benign mesothelioma, MIXED TISSUE TUMORS, mesenchymal hamartoma, benign teratoma, MISCELLANEOUS, adrenal rest tumours, pancreatic rest
(12 Dec 1998)
brain tumours Can be malignant or benign and can occur at any age. Primary brain tumours initially form in the brain tissue. Secondary brain tumours are cancers that have spread to the brain tissue (metastasized) from tissue elsewhere in the body.
(12 Dec 1998)
pancreatic isleT-cell tumours <radiology> Insulinoma (beta-cell), usually solitary, 85% benign, gastrinoma, small, slow-growing, multiple, 60% malignant, Zollinger-Ellison syndrome: mult. Intractable ulcers, VIPoma, vasoactive intestinal peptide (VIP), WDHA syndrome: watery diarrhoea, hypokalaemia, achlorhydria, Verner-Morrison syndrome, glucagonoma, hyperglycaemia, migratory necrolytic erythema APUDomas, associated with MEN-1
(12 Dec 1998)
malignant liver tumours <radiology> EPITHELIAL TUMORS, hepatocellular, hepatoblastoma (7%), hepatocellular carcinoma (HCC) (75%), cholangiocellular (6%), cholangiocarcinomarcinoma, cystadenocarcinoma, MESENCHYMAL TUMORS, tumours of blood vessels, angiosarcoma, haemangioendothelioma, other tumours, embryonal sarcoma, fibrosarcoma, TUMORS OF MUSCLE TISSUE, leiomyosarcoma, rhabdomyosarcoma, MISCELLANEOUS, carcinosarcoma, teratoma, yolk sac tumour, carcinoid, squamous carcinoma, primary lymphoma see: benign liver tumours
(12 Dec 1998)
venereal tumours, veterinary Tumours most commonly seen on or near the genitalia. They are venereal, most likely transmitted through transplantation of cells by contact. Metastases have been reported. Spontaneous regression may occur.
(12 Dec 1998)
giant cell tumours Tumours of bone tissue or synovial or other soft tissue characterised by the presence of giant cells. The most common are giant cell tumour of tendon sheath and giant cell tumour of bone.
(12 Dec 1998)
pineal region tumours Type of brain tumours.
(12 Dec 1998)
pineal tumours <radiology> SIGNS: aqueductal obstruction most likely to be hydrocephalus, paralysis of upward gaze (due to pressure on quarigeminal plate), precocious puberty, symptoms of hypothalamic, thalamic, cerebellar or pyramidal lesion TYPES: germ-cell (teratoid) tumours, teratoma, germinoma / atypical teratoma, endodermal sinus (yolk sac) tumour, choriocarcinoma, pineal-cell tumours, pineocytoma, pineo---, others, glioma, ganglioneuroma, ganglioglioma
(12 Dec 1998)
plant tumours A localised proliferation of plant tissue forming a swelling or outgrowth, commonly with a characteristic shape and unlike any organ of the normal plant. Plant tumours or galls usually form in response to the action of a pathogen or a pest.
(12 Dec 1998)
posterior fossa tumours <radiology> Midline, medulloblastoma (hyperdense, enhances), astrocytoma (hypodense, enhances), 4th ventricle, ependymoma (most common, slow-growing, expands ventricle), medulloblastoma (usually obliterates ventricular cavity), choroid plexus papilloma (more common in lateral ventricles)
(12 Dec 1998)
primitive neuroectodermal tumours A type of brain tumour. Prenatal diagnosis: diagnosis before birth. Methods for prenatal diagnosis include ultrasound (of the uterus, placenta and developing foetus), chorionic villus sampling to obtain tissue for chromosome or biochemical analysis, amniocentesis to obtain amniotic fluid for the analysis of chromosmes, enzymes, DNA, etc. A growing number of birth defects and diseases are now amenable to prenatal diagnosis. Also called antenatal diagnosis.
(12 Dec 1998)
nerve sheath tumours Tumours arising in the sheath surrounding the axon of some nerve cells and formed by the plasma membrane of schwann cells in the peripheral nervous sytem and by oligodendrocytes in the central nervous system. Neurofibromas and neurilemmomas are the most commonly occurring tumours of this type.
(12 Dec 1998)
neuroectodermal tumours Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells.
(12 Dec 1998)
neuroendocrine tumours Tumours whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumours include ectopic hormone production (often via apud cells), the presence of tumour-associated antigens, and isozyme composition.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ovarian
    ³­¼ÒÀÇ;¾¾¹æÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á